Pulmonary hyperinflation due to gas trapping and pulmonary artery size: The MESA COPD Study
- PMID: 28463971
- PMCID: PMC5413010
- DOI: 10.1371/journal.pone.0176812
Pulmonary hyperinflation due to gas trapping and pulmonary artery size: The MESA COPD Study
Abstract
Background: Pulmonary hypertension is associated with increased morbidity and mortality in chronic obstructive pulmonary disease (COPD). Since pulmonary artery (PA) size increases in pulmonary hypertension, we measured PA cross-sectional area using magnetic resonance imaging (MRI) to test the hypothesis that pulmonary hyperinflation due to gas trapping is associated with PA cross-sectional area in COPD.
Methods: The MESA COPD Study recruited participants with COPD and controls from two population-based cohort studies ages 50-79 years with 10 or more pack-years and free of clinical cardiovascular disease. Body plethysmography was performed according to standard criteria. Cardiac MRI was performed at functional residual capacity to measure the cross-sectional area of the main PA. Percent emphysema was defined as the percentage of lung voxels less than -950 Hounsfield units as assessed via x-ray computed tomography. Analyses were adjusted for age, gender, height, weight, race-ethnicity, the forced expiratory volume in one second, smoking status, pack-years, lung function, oxygen saturation, blood pressure, left ventricular ejection fraction and percent emphysema.
Results: Among 106 participants, mean residual volume was 1.98±0.71 L and the mean PA cross-sectional area was 7.23±1.72 cm2. A one standard deviation increase in residual volume was independently associated with an increase in main PA cross-sectional area of 0.55 cm2 (95% CI 0.18 to 0.92; p = 0.003). In contrast, there was no evidence for an association with percent emphysema or total lung capacity.
Conclusion: Increased residual volume was associated with a larger PA in COPD, suggesting that gas trapping may contribute to pulmonary hypertension in COPD.
Conflict of interest statement
Figures

Similar articles
-
Pulmonary artery stiffness in chronic obstructive pulmonary disease (COPD) and emphysema: The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study.J Magn Reson Imaging. 2018 Jan;47(1):262-271. doi: 10.1002/jmri.25753. Epub 2017 May 10. J Magn Reson Imaging. 2018. PMID: 28488348 Free PMC article.
-
Not all measures of hyperinflation are created equal: lung structure and clinical correlates of gas trapping and hyperexpansion in COPD: the Multi-Ethnic Study of Atherosclerosis (MESA) COPD Study.Chest. 2014 Jun;145(6):1305-1315. doi: 10.1378/chest.13-1884. Chest. 2014. PMID: 24481056 Free PMC article.
-
Percent Emphysema and Daily Motor Activity Levels in the General Population: Multi-Ethnic Study of Atherosclerosis.Chest. 2017 May;151(5):1039-1050. doi: 10.1016/j.chest.2016.11.033. Epub 2016 Dec 6. Chest. 2017. PMID: 27940190 Free PMC article.
-
Quantitative computed tomography measurements to evaluate airway disease in chronic obstructive pulmonary disease: Relationship to physiological measurements, clinical index and visual assessment of airway disease.Eur J Radiol. 2016 Nov;85(11):2144-2151. doi: 10.1016/j.ejrad.2016.09.010. Epub 2016 Sep 13. Eur J Radiol. 2016. PMID: 27776670 Free PMC article. Review.
-
Assessing pulmonary hypertension in COPD. Is there a role for computed tomography?Int J Chron Obstruct Pulmon Dis. 2019 Sep 4;14:2065-2079. doi: 10.2147/COPD.S207363. eCollection 2019. Int J Chron Obstruct Pulmon Dis. 2019. PMID: 31564854 Free PMC article. Review.
Cited by
-
Functional Predictors Discriminating Asthma-COPD Overlap (ACO) from Chronic Obstructive Pulmonary Disease (COPD).Int J Chron Obstruct Pulmon Dis. 2022 Oct 21;17:2723-2743. doi: 10.2147/COPD.S382761. eCollection 2022. Int J Chron Obstruct Pulmon Dis. 2022. PMID: 36304971 Free PMC article.
-
Management of Pulmonary Hypertension Due to Chronic Lung Disease.Methodist Debakey Cardiovasc J. 2021 Jul 1;17(2):124-133. doi: 10.14797/ZKUT3813. eCollection 2021. Methodist Debakey Cardiovasc J. 2021. PMID: 34326932 Free PMC article.
-
Chest Computed Tomography to Improve Phenotyping in Pulmonary Hypertension Associated with Chronic Obstructive Pulmonary Disease.Ann Am Thorac Soc. 2025 Feb;22(2):175-180. doi: 10.1513/AnnalsATS.202408-878PS. Ann Am Thorac Soc. 2025. PMID: 39556097 No abstract available.
-
Reproducibility and Changes in Vena Caval Blood Flow by Using 4D Flow MRI in Pulmonary Emphysema and Chronic Obstructive Pulmonary Disease (COPD): The Multi-Ethnic Study of Atherosclerosis (MESA) COPD Substudy.Radiology. 2019 Sep;292(3):585-594. doi: 10.1148/radiol.2019182143. Epub 2019 Jul 23. Radiology. 2019. PMID: 31335282 Free PMC article.
-
The Emerging Biomarkers in Chronic Obstructive Pulmonary Disease: A Narrative Review.Diagnostics (Basel). 2025 May 14;15(10):1245. doi: 10.3390/diagnostics15101245. Diagnostics (Basel). 2025. PMID: 40428238 Free PMC article. Review.
References
-
- Oswald-Mammosser M, Weitzenblum E, Quoix E, Moser G, Chaouat A, Charpentier C, et al. Prognostic factors in COPD patients receiving long-term oxygen therapy. Importance of pulmonary artery pressure. Chest. 1995;107(5):1193–8. Epub 1995/05/01. - PubMed
-
- Kessler R, Faller M, Fourgaut G, Mennecier B, Weitzenblum E. Predictive factors of hospitalization for acute exacerbation in a series of 64 patients with chronic obstructive pulmonary disease. American journal of respiratory and critical care medicine. 1999;159(1):158–64. Epub 1999/01/05. 10.1164/ajrccm.159.1.9803117 - DOI - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical